Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
LOTRIMIN ULTRA |
| Manufacturer |
|
Schering-Plough Healthcare Products |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Benzylamine antifungal. |
| Generic Name |
|
Butenafine HCl 1%; crm. |
| Indications |
|
Tinea pedis, t. cruris, t. corporis. |
| Children |
|
Not recommended. |
| Adults |
|
T. corporis, t. cruris: apply once daily for 2 weeks. T. pedis: apply twice daily for 1 week or once daily for 4 weeks. |
| Precautions |
|
Avoid eyes, nose, mouth, mucous membranes. Do not occlude. Discontinue if irritation develops and confirm diagnosis. Sensitivity to allylamines. |
| Adverse Reactions |
|
Burning/stinging, worsening of condition, other local irritation. |
| How Supplied |
|
Crm: 12 g, 24 g |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
